Observational studyCNS drugs2022

Impact of Natural Killer (NK) Cells on Immune Reconstitution, and Their Potential as a Biomarker of Disease Activity, in Alemtuzumab-Treated Patients with Relapsing Remitting Multiple Sclerosis: An Observational Study.

Serena Palmeri et al.PubMed ↗Publisher ↗

No numbers read from the abstract.